Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 22 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| HTG Molecular Diagnostics Inc (CE) | HTGMQ | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0025 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0025 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 3 | 22 | - | 0.0013 - 0.66 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:05:55 | 1 | $ 0.09 | USD |
HTG Molecular Diagnostics Inc (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 5.54k | 2.21M | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
HTG Molecular Diagnostics (CE) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HTGMQ Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.10 | 0.10 | 0.0025 | 0.0025 | 1,414 | -0.0975 | -97.50% |
| 1 Month | 0.0025 | 0.10 | 0.0015 | 0.0020924 | 1,179 | 0.00 | 0.00% |
| 3 Months | 0.0015 | 0.10 | 0.0013 | 0.0017653 | 1,439 | 0.001 | 66.67% |
| 6 Months | 0.0013 | 0.26 | 0.0013 | 0.0028369 | 4,013 | 0.0012 | 92.31% |
| 1 Year | 0.41 | 0.66 | 0.0013 | 0.3556989 | 12,208 | -0.4075 | -99.39% |
| 3 Years | 0.41 | 0.66 | 0.0013 | 0.3556989 | 12,208 | -0.4075 | -99.39% |
| 5 Years | 0.41 | 0.66 | 0.0013 | 0.3556989 | 12,208 | -0.4075 | -99.39% |
HTG Molecular Diagnostics (CE) Description
| HTG's mission is to advance the promise of precision medicine through innovative transcriptome-wide profiling technology designed to accelerate the development of diagnostics and hasten the discovery of novel drug candidates to effect lifechanging outcomes. The company's proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery. |
